FATE
Price
$1.57
Change
-$0.10 (-5.95%)
Updated
Dec 23, 11:28 AM (EDT)
70 days until earnings call
PTN
Price
$0.98
Change
+$0.12 (+13.95%)
Updated
Dec 20, 04:59 PM (EDT)
57 days until earnings call
Ad is loading...

FATE vs PTN

Header iconFATE vs PTN Comparison
Open Charts FATE vs PTNBanner chart's image
Fate Therapeutics
Price$1.57
Change-$0.10 (-5.95%)
Volume$200
CapitalizationN/A
Palatin Technologies
Price$0.98
Change+$0.12 (+13.95%)
Volume$679
CapitalizationN/A
FATE vs PTN Comparison Chart
Loading...
FATE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PTN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FATE vs. PTN commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FATE is a Hold and PTN is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (FATE: $1.68 vs. PTN: $0.97)
Brand notoriety: FATE and PTN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FATE: 307% vs. PTN: 777%
Market capitalization -- FATE: $192.48M vs. PTN: $22.7M
FATE [@Biotechnology] is valued at $192.48M. PTN’s [@Biotechnology] market capitalization is $22.7M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FATE’s FA Score shows that 1 FA rating(s) are green whilePTN’s FA Score has 0 green FA rating(s).

  • FATE’s FA Score: 1 green, 4 red.
  • PTN’s FA Score: 0 green, 5 red.
According to our system of comparison, FATE is a better buy in the long-term than PTN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FATE’s TA Score shows that 3 TA indicator(s) are bullish while PTN’s TA Score has 5 bullish TA indicator(s).

  • FATE’s TA Score: 3 bullish, 6 bearish.
  • PTN’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, PTN is a better buy in the short-term than FATE.

Price Growth

FATE (@Biotechnology) experienced а -8.20% price change this week, while PTN (@Biotechnology) price change was +10.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.80%. For the same industry, the average monthly price growth was -3.49%, and the average quarterly price growth was +2.96%.

Reported Earning Dates

FATE is expected to report earnings on Mar 03, 2025.

PTN is expected to report earnings on Feb 18, 2025.

Industries' Descriptions

@Biotechnology (-2.80% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FATE($192M) has a higher market cap than PTN($22.7M). FATE YTD gains are higher at: -55.080 vs. PTN (-75.681). PTN has higher annual earnings (EBITDA): -32.01M vs. FATE (-177.57M). FATE has more cash in the bank: 297M vs. PTN (2.38M). PTN has less debt than FATE: PTN (470K) vs FATE (99M). FATE has higher revenues than PTN: FATE (13.4M) vs PTN (2.38M).
FATEPTNFATE / PTN
Capitalization192M22.7M846%
EBITDA-177.57M-32.01M555%
Gain YTD-55.080-75.68173%
P/E RatioN/AN/A-
Revenue13.4M2.38M562%
Total Cash297M2.38M12,458%
Total Debt99M470K21,064%
FUNDAMENTALS RATINGS
FATE vs PTN: Fundamental Ratings
FATE
PTN
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
18
Undervalued
72
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
9465
P/E GROWTH RATING
1..100
10095
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

FATE's Valuation (18) in the Biotechnology industry is somewhat better than the same rating for PTN (72). This means that FATE’s stock grew somewhat faster than PTN’s over the last 12 months.

FATE's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as PTN (100). This means that FATE’s stock grew similarly to PTN’s over the last 12 months.

FATE's SMR Rating (97) in the Biotechnology industry is in the same range as PTN (100). This means that FATE’s stock grew similarly to PTN’s over the last 12 months.

PTN's Price Growth Rating (65) in the Biotechnology industry is in the same range as FATE (94). This means that PTN’s stock grew similarly to FATE’s over the last 12 months.

PTN's P/E Growth Rating (95) in the Biotechnology industry is in the same range as FATE (100). This means that PTN’s stock grew similarly to FATE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
FATEPTN
RSI
ODDS (%)
Bullish Trend 5 days ago
88%
Bullish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
72%
Momentum
ODDS (%)
Bearish Trend 4 days ago
87%
Bullish Trend 4 days ago
74%
MACD
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
89%
Bullish Trend 4 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
82%
Advances
ODDS (%)
Bullish Trend 15 days ago
86%
Bullish Trend 4 days ago
79%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
84%
Bullish Trend 7 days ago
85%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
88%
View a ticker or compare two or three
Ad is loading...
FATE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PTN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FRIQX11.810.06
+0.54%
Fidelity Advisor Real Estate Income M
HSMVX13.670.06
+0.44%
Hartford Small Cap Value R6
RYPRX10.920.04
+0.37%
Royce Premier Invmt
RBCIX8.620.02
+0.23%
RBC China Equity I
MPLAX13.09N/A
N/A
Praxis International Index A

PTN and

Correlation & Price change

A.I.dvisor indicates that over the last year, PTN has been loosely correlated with FATE. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if PTN jumps, then FATE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTN
1D Price
Change %
PTN100%
+12.55%
FATE - PTN
41%
Loosely correlated
+1.20%
MDGL - PTN
32%
Poorly correlated
+5.12%
KRYS - PTN
32%
Poorly correlated
+2.49%
AVCTF - PTN
30%
Poorly correlated
-5.29%
DNLI - PTN
30%
Poorly correlated
-0.19%
More